|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.185 USD | -1.25% |
|
-0.84% | -49.36% |
| 07-27 | Spero Therapeutics, Inc. Announces Appointment of Debra Jeske Zack as Chief Medical Officer | CI |
| 07-15 | Innovent Biologics Shares Surge on Spero Deal That Could Be Worth $1.1 Billion | DJ |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 1.58 | 2.02 | 1.89 |
| Spread/Res. | -25.32% | -41.58% | -37.57% |
| Spread/Supp. | +1.72% | +1.72% | -0.84% |
| Support | 1.16 | 1.16 | 1.19 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SPRO Stock
- Charts Spero Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
